stella
beta
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer — Stella
Recruiting
Back to Recurrent Non-small Cell Lung Cancer trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(3 sites)
China
China-Japan Union Hospital, Jilin University, Changchun, Jilin
Shanghai 10th People's Hospital, Shanghai
Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai
View full record on ClinicalTrials.gov